Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.24.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2 $ 156,017 $ (108,484) $ 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement net of $8 issuance costs (**) [2] [1] 273 273
Issuance of Common Stock under Open Market Sales Agreement net of $8 issuance costs (**) (in Shares) [2] 229,044      
Stock-based compensation expenses 1,529 1,529
Proceeds on account of shares (***) [3] 19 19
Proceeds on account of shares (***) (in Shares) [3]      
Net loss (28,317) (28,317)
Balance at Dec. 31, 2022 $ 2 157,838 (136,801) 21,039
Balance (in Shares) at Dec. 31, 2022 29,976,582      
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $333 issuance costs (**) [2] $ 1 7,151 7,152
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $333 issuance costs (**) (in Shares) [2] 15,997,448      
Reissuance of treasury stock (***) [3]
Reissuance of treasury stock (***) (in Shares) [3] 5,700      
Stock-based compensation expenses 1,059 1,059
Issuance of Common Stock under Open Market Sales Agreement (**) [2] [1] [1] [1]
Issuance of Common Stock under Open Market Sales Agreement (**) (in Shares) [2] 200      
Net loss (26,169) (26,169)
Balance at Dec. 31, 2023 $ 3 $ 166,048 $ (162,970) $ 3,081
Balance (in Shares) at Dec. 31, 2023 45,979,930      
[1] Less than $1.
[2] See note 12A.
[3] See note 9A.